Molecular analysis of the subtype-selective inhibition of cloned KATP channels by PNU-37883A

Br J Pharmacol. 2004 Mar;141(5):867-73. doi: 10.1038/sj.bjp.0705670. Epub 2004 Feb 2.

Abstract

1. In this study, we have used Kir6.1/Kir6.2 chimeric proteins and current recordings to investigate the molecular basis of PNU-37883A inhibition of cloned K(ATP) channels. 2. Rat Kir6.1, Kir6.2 and Kir6.1/Kir6.2 chimeras were co-expressed with either SUR2B or SUR1, following RNA injection into Xenopus oocytes, and fractional inhibition of K(ATP) currents by 10 microm PNU-37883A reported. 3. Channels containing Kir6.1/SUR2B were more sensitive to inhibition by PNU-37883A than those containing Kir6.2/SUR2B (mean fractional inhibition: 0.70, cf. 0.07). 4. On expression with SUR2B, a chimeric channel with the Kir6.1 pore and the Kir6.2 amino- and carboxy-terminal domains was PNU-37883A insensitive (0.06). A chimera with the Kir6.1 carboxy-terminus and Kir6.2 amino-terminus and pore was inhibited (0.48). These results, and those obtained with other chimeras, suggest that the C-terminus is an important determinant of PNU-37883A inhibition of Kir6.1. Similar results were seen when constructs were co-expressed with SUR1. Further chimeric constructs localised PNU-37883A sensitivity to an 81 amino-acid residue section in the Kir6.1 carboxy-terminus. 5. Our data show that structural differences between Kir6.1 and Kir6.2 are important in determining sensitivity to PNU-37883A. This compound may prove useful in probing the structural and functional differences between the two channel subtypes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adamantane / analogs & derivatives*
  • Adamantane / pharmacology*
  • Adenosine Triphosphate / genetics
  • Adenosine Triphosphate / physiology
  • Animals
  • Cloning, Molecular / drug effects
  • Cloning, Molecular / methods*
  • Dose-Response Relationship, Drug
  • Female
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Morpholines / pharmacology*
  • Potassium Channel Blockers / pharmacology*
  • Potassium Channels
  • Rats
  • Xenopus laevis

Substances

  • Membrane Proteins
  • Morpholines
  • Potassium Channel Blockers
  • Potassium Channels
  • mitochondrial K(ATP) channel
  • U 37883A
  • Adenosine Triphosphate
  • Adamantane